We will likely see more growth in healthcare, namely in rural areas, so TDOC is positioned well. But this stock will be pressured in coming months, because of its high PE. If you enter any high-PE stock, buy just a partial position then add on volatility. TDOC is down 28% from its high.
2022 sector outlook Concerned about Q1-2022. She predicts a rotation from growth into cyclical in 2022. Look outside the U.S. for cyclical exposure. Be ready to step in during pullbacks. She expects positive returns in 2022, but not as high as 2021.
Retails investors who are pre- and current retirement will be tailwinds for Schwab. Will also benefit from the yield spread. Financial services as a whole will improve. She's bullish banks.
Likes the life sciences and diagnostics exposure here. DHR is a serial acquirer, starting to divest businesses. You can take some profits and buy Stryker.
He's buying nothing now, but would add to Twilio or PayPal (owns both), and would add in Q1 on pullbacks. First, he wants to see how interest rates move (or not) in Q1. He expects rates to slowly march higher. Also, he needs to see what happens to Covid to see if they knock down the cyclicals. He's a market seller, not a buyer now.
He's buying nothing now, but would add to Twilio or PayPal (owns both), and would add in Q1 on pullbacks. First, he wants to see how interest rates move (or not) in Q1. He expects rates to slowly march higher. Also, he needs to see what happens to Covid to see if they knock down the cyclicals. He's a market seller, not a buyer now.
He's raising a cash. The S&P hasn't fallen more than 6% in the past year, because the Fed keeps buying bonds which keeps pumping cash into the financial system, which in turn buys every dip. BUT this will stop on Q1. He loves this! It's opportunity. There'll be more volatility. He'll buy then. The US 10-year will surpass 2% because of economic activity and the end of the Fed's bond-buying. Be ready.
Bank outlook Many positives, starting with loan growth demand from infrastructure spending mostly. Also, continued improving labour markets means more credit card use and home/mortgage demand, all good for banks. Meanwhile, stock trading will rise to help trading desks at the banks.
His favourite stock for 2022. Shares are down since its all-time high in October, because steel prices declined a little, but remain high. Gross margins and volumes remain high and will stay so, because car production is rising and people are being major appliances as they buy new houses. PLus, infrastructure spending is coming. All tailwinds. $2.5 billion free cash flow projected for 2022 or 25% free cash flow yield. Stick with it.
IBB gives him exposure to Moderna, its largest holding, and yet there's no single-company risk here. Biotechs have been under a lot of pressure this year, so he sees an opportunity (past of the pressure has been from shorting) if you're patient. He likes the future of biotech.
US interest rates There'll be more volatility in 2022 and the US 10-year will pass 2% without inverting the yield curve. The Fed did the right thing to raise rates. A wild card could be China will scare Taiwan after the Olympics. China could sell American paper to rattle American markets. He's fully invested now, but will pare positions in Q1-2022 to buy dips. Raising rates in the near term won't tamp down inflation.
U.S. bank forecast The yield curve won't invert. If so, it will pressure the bank margins. The banks had a good catch-up in 2021. You have to own them because of coming loan growth. Also, he sees M&A increasing a lot in 2022, another tailwind.